Corcept Therapeutics (CORT) Receivables - Other (2019 - 2026)
Corcept Therapeutics (CORT) posted Receivables - Other of $4.5 million for Q2 2026, up 15.38% sequentially from $3.9 million in Q3 2025, and up 9.76% YoY from $4.1 million in Q2 2025.
Corcept Therapeutics (CORT) Receivables - Other (2019 - 2026) Analysis & Trends
Corcept Therapeutics has reported Receivables - Other for 8 years, with the latest figure at $4.5 million in Q2 2026.
- Quarterly Receivables - Other rose 9.76% year-over-year to $4.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.5 million (up 9.76% YoY) and the FY2025 annual result came in at $4.1 million, up 129.29% from the prior year.
- Receivables - Other advanced to $4.5 million in Q2 2026 per CORT's latest filing, from $3.9 million in the prior quarter.
- Over five years, Receivables - Other peaked at $18.2 million in Q1 2025 and troughed at -$14.0 million in Q1 2024.
- A 5-year average of $5.8 million and a median of $4.0 million in 2025 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other jumped 1455.56% in 2023, then plunged 200.0% in 2024.
- Over 5 years, Receivables - Other stood at $14.0 million in 2022, then changed by 0.0% to $14.0 million in 2023, then sank by 79.29% to $2.9 million in 2024, then soared by 34.48% to $3.9 million in 2025, then rose by 15.38% to $4.5 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $4.5 million, $3.9 million, and $4.1 million for Q2 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.50 Mn |
| Jun 30, 2026 | 4.50 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Mar 31, 2023 | 14.00 Mn |